Westminster Irbesartan Tablets recalled over manufacturing violations
- Recall date
- October 29, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Westminster Pharmaceuticals Llc recalls Westminster Irbesartan Tablets, USP 75 mg Rx Only Manufactured by: ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788 Ma…
- Recall number
- D-0300-2019
- FDA classification
- Class II
- Brand / firm
- Westminster Pharmaceuticals Llc
- Sold / distributed
- Nationwide.
Why it was recalled
CGMP Deviations: FDA laboratory testing confirmed traces of NDEA impurity in specific lots of Irbesartan.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Westminster Irbesartan Tablets, USP 75 mg Rx Only Manufactured by: ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788 Manufactured for: Westminster Pharmaceuticals, LLC. Olive Branch, MS 38654 a) 30 count bottle NDC 69367-119-01; b) 90 count bottle NDC 69367-119-03
Get recall alerts
Free email alert whenever Westminster Pharmaceuticals Llc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Westminster Pharmaceuticals Llc